沫舒坦辅助治疗重型颅脑损伤伴肺炎疗效观察
Zhejiang Journal of Integrated Traditional Chinese and Western Medicine(2014)
Abstract
重型颅脑损伤为致死率、致残率高并发症多的神经外科疾病,肺部感染是最常见的并发症之一,处于昏迷状态的患者一旦发生肺部感染,就会加重病情,易导致患者预后不良,致残率及死亡率增加[1]。沫舒坦(ambroxol hydrochloride,Amb)针剂系具有多种生物学效应的黏液溶解剂,最早用于治疗新生儿呼吸窘迫综合征[2],其独特的肺保护作用越来越受到重视。本文旨在探讨应用沫舒坦治疗重型颅脑损伤合并肺炎的疗效及其在临床应用的意义。
MoreAI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined